Medrol is the trade name and the generic name is Methylprednisolone Tablets. Methylprednisolone tablets are synthetic glucocorticoids with analgesic, anti-inflammatory, anti-allergic, immunosuppressive and anti-shock effects. Methylprednisolone tablets are used for non-endocrine disorders, including rheumatic diseases, connective tissue diseases, skin diseases, allergic diseases, eye diseases, respiratory diseases, hematological diseases, tumors, edema, gastrointestinal diseases, etc.; and also used for endocrine disorders, including adrenocortical insufficiency, congenital adrenal hyperplasia, non-suppurative thyroiditis, and hypercalcemia due to cancer. Adverse reactions include: infections, endocrine disorders, allergic reactions, metabolic acidosis, sodium retention, leukocytosis, mental abnormalities, increased intracranial pressure, dizziness, headache, gastrointestinal system disorders, elevated liver enzymes, cardiac arrhythmia, edema, hirsutism, rash, hyperhidrosis, arthralgia, myalgia, weakness, menstrual disorders, fatigue and other symptoms. In addition, Methylprednisolone Tablets are contraindicated in patients who are allergic to the components of Methylprednisolone Tablets, systemic fungal infections are contraindicated, and it is prohibited to use live or live attenuated vaccines in people who are undergoing immunosuppressive dosage therapy with corticosteroids. Children, diabetes mellitus, hypertension, history of psychiatric disorders, patients with certain infectious or viral diseases presenting with visible symptoms belong to the risk group and need to be careful with the use of the drug. It should also be noted that the use of high-dose corticosteroids during pregnancy may cause fetal malformations and should only be used under medical supervision after weighing the benefits against the potential risks to the fetus. If you need to use Methylprednisolone Tablets, please consult your healthcare professional and follow your doctor’s instructions.